Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:ergotamine
go back to main search page
Accession:CHEBI:64318 term browser browse the term
Definition:A peptide ergot alkaloid that is dihydroergotamine in which a double bond replaces the single bond between positions 9 and 10.
Synonyms:exact_synonym: (5'alpha)-5'-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxoergotaman
 related_synonym: (5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione;   12'-hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione;   Ergotamin;   Formula=C33H35N5O5;   Gynergen;   InChI=1S/C33H35N5O5/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32/h3-6,8-11,15,17,21,25-27,34,42H,7,12-14,16,18H2,1-2H3,(H,35,39)/t21-,25-,26+,27+,32-,33+/m1/s1;   InChIKey=XCGSFFUVFURLIX-VFGNJEKYSA-N;   SMILES=[H][C@@]12Cc3c[nH]c4cccc(C1=C[C@H](CN2C)C(=O)N[C@]1(C)O[C@]2(O)N([C@@H](Cc5ccccc5)C(=O)N5CCC[C@@]25[H])C1=O)c34;   ergotamina;   ergotaminum
 xref: Beilstein:78890 "ChemIDplus";   CAS:113-15-5 "ChemIDplus";   CAS:113-15-5 "KEGG DRUG";   CAS:113-15-5 "NIST Chemistry WebBook";   DrugBank:DB00696;   Drug_Central:1043 "DrugCentral";   KEGG:C07544;   KEGG:D07906
 xref_mesh: MESH:D004878
 xref: PMID:10560569 "Europe PMC";   PMID:10611116 "Europe PMC";   PMID:11386387 "Europe PMC";   PMID:12463275 "Europe PMC";   PMID:12525272 "Europe PMC";   PMID:12558771 "Europe PMC";   PMID:21181611 "Europe PMC";   PMID:21512122 "Europe PMC";   PMID:21878097 "Europe PMC";   PMID:21879189 "Europe PMC";   PMID:22347148 "Europe PMC";   PMID:22414189 "Europe PMC";   PMID:22417229 "Europe PMC";   PMID:22441761 "Europe PMC";   PMID:22444161 "Europe PMC";   PMID:22446707 "Europe PMC";   PMID:23243949 "Europe PMC";   PMID:24035295 "Europe PMC";   PMID:8825693 "Europe PMC";   PMID:9009470 "Europe PMC";   PMID:9032799 "Europe PMC";   Reaxys:78890 "Reaxys";   Wikipedia:Ergotamine


show annotations for term's descendants       view all columns           Sort by:
 
ergotamine term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Calca calcitonin-related polypeptide alpha JBrowse link 1 184,184,018 184,188,922 RGD:6480464
G Casp3 caspase 3 JBrowse link 16 48,845,011 48,863,249 RGD:6480464
G Fos Fos proto-oncogene, AP-1 transcription factor subunit JBrowse link 6 109,300,433 109,303,299 RGD:6480464
G Gstp1 glutathione S-transferase pi 1 JBrowse link 1 219,291,679 219,294,147 RGD:6480464
G Htr2b 5-hydroxytryptamine receptor 2B JBrowse link 9 93,112,781 93,130,135 RGD:6480464

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19669
    role 19613
      biological role 19611
        pharmacological role 18684
          analgesic 13037
            non-narcotic analgesic 11941
              ergotamine 5
Path 2
Term Annotations click to browse term
  CHEBI ontology 19669
    subatomic particle 19665
      composite particle 19665
        hadron 19665
          baryon 19665
            nucleon 19665
              atomic nucleus 19665
                atom 19665
                  main group element atom 19545
                    p-block element atom 19545
                      carbon group element atom 19428
                        carbon atom 19420
                          organic molecular entity 19420
                            organic group 18343
                              cyclic organic group 1822
                                organic heterobicyclic ring 1822
                                  indole skeleton 1822
                                    indole alkaloid 1822
                                      terpenoid indole alkaloid 1462
                                        hemiterpenoid indole alkaloid 24
                                          ergot alkaloid 24
                                            peptide ergot alkaloid 5
                                              ergotamine 5
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.